A61P 31 - Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics

Patents for A61P 31 - Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics (179,784)
08/2002
08/13/2002	US6433451 Method and electric motor with rotational stator
08/13/2002	US6433177 Reacting n-carboxyanhydride and butylamine
08/13/2002	US6433151 Erythromycin derivatives, a process for their preparation and their use as medicaments
08/13/2002	US6433150 Antitumor agents
08/13/2002	US6433148 Immunoglobulin antibodies with amino acid sequences
08/13/2002	US6433143 Tie-2 ligands
08/13/2002	US6433140 Stable bactericidal permeability-increasing protein products and pharmaceutical compositions containing the same
08/13/2002	US6433022 Exposure of semen to naphthoquinone/1,4-/ or juglone; reduction to semiquinone and generation of oxygen, superoxide, hydrogen peroxide, or free radicals; immobilization
08/13/2002	US6432973 Polyoxyethylated hydroxyesters of rapamycin useful in inducing immunosuppression and in the treatment of transplantation rejection, autoimmune diseases, solid tumors, fungal infections, and vascular disease.
08/13/2002	US6432966 Antiviral combinations
08/13/2002	US6432962 Antiinflammatory agents
08/13/2002	US6432948 Use of 7-(2-oxa-5,8-diazabicylco[4.3.0]non-8-yl)-quinolone carboxylic acid and naphthyridon carboxylic acid derivatives for the treatment of heliobacter pylori infections and associated gastroduodenal diseases
08/13/2002	US6432935 Synergistic mixture of antibiotic, sulfadimidine and fungicide
08/13/2002	US6432922 Antitumor agents; angiogenesis inhibitors
08/13/2002	US6432703 Isolated polynucleotide sequences
08/13/2002	US6432675 Combinatorial polypeptide antigens
08/13/2002	US6432412 Active immunization using a siderophore receptor protein
08/13/2002	US6432411 Recombinant envelope vaccine against flavivirus infection
08/13/2002	US6432409 Hybrid peptides modulate the immune response
08/13/2002	US6432396 Sterilization, medical devices, bactericide, fungicide, viricide: palladium or platinum complex having methine or imine group reacted with vinyl polymers, polyurethanes, or polyolefins; thermally induced phase separation membrane of
08/13/2002	CA2127987C Pharmaceutical bacteriocin compositions
08/13/2002	CA2122604C Uses of aloe products, e.g. acemannan, in the treatment of diseases requiring intervention of the immune system for cure
08/13/2002	CA2095526C Compound and compositions useful as antifungal agents
08/13/2002	CA2063938C Novel azadecalin amides and thioamides as inhibitors of cholesterol biosynthesis
08/08/2002	WO2002061110A2 Nucleic acid derivatives
08/08/2002	WO2002061105A2 Chimeric molecules containing a module able to target specific cells and a module regulating the apoptogenic function of the permeability transition pore complex (ptpc)
08/08/2002	WO2002061086A2 Human leucine-rich repeat containing protein expressed predominately in small intestine, hlrrsi1
08/08/2002	WO2002061070A2 Environmentally regulated genes, involved in the virulence of streptococcus suis
08/08/2002	WO2002060949A2 Glycoforms a fas ligand inhibitory protein analog
08/08/2002	WO2002060936A2 Vaccine and compositions for the prevention and treatment of neisserial infections
08/08/2002	WO2002060935A2 A chimeric protein comprising non-toxic pseudomonas exotoxin a and type iv pilin sequences
08/08/2002	WO2002060926A2 Hepatitis c tripeptide inhibitors
08/08/2002	WO2002060924A2 Identification and applications of porcine reproductive and respiratory syndrome virus host susceptibility factor(s) for improved swine breeding and development of a non-simian recombinant cell line for propagation of the virus and a target for a novel class of antiviral compounds
08/08/2002	WO2002060919A2 Molecules with extended half-lives, compositions and uses thereof
08/08/2002	WO2002060912A1 14-membered macrolides derived from leucomycins
08/08/2002	WO2002060898A1 Thiazolyl-, oxazolyl-, pyrrolyl-, and imidazolyl-acid amide derivatives useful as inhibitors of pde4 isozymes
08/08/2002	WO2002060897A2 Process for making substituted 8-arylquinolinium benzenesulfonate
08/08/2002	WO2002060896A1 Ether derivatives useful as inhibitors of pde4 isozymes
08/08/2002	WO2002060894A2 Sulfonamide lactam inhibitors of factor xa
08/08/2002	WO2002060879A2 Bacterial gyrase inhibitors and uses thereof
08/08/2002	WO2002060877A1 Imidazole derivatives
08/08/2002	WO2002060875A1 Nicotinamide biaryl derivatives useful as inhibitors of pde4 isozymes
08/08/2002	WO2002060869A2 Use of p38 inhibitors for the treatment of inflammation-enhanced cough
08/08/2002	WO2002060868A2 Inhibitors of prenyl-protein transferase
08/08/2002	WO2002060859A2 Cyclic derivatives as modulators of chemokine receptor activity
08/08/2002	WO2002060856A1 Novel quaternary ammonium salt compounds, process for producing the same and use thereof
08/08/2002	WO2002060492A1 Methods of inhibiting kinases
08/08/2002	WO2002060485A2 Use of immunoregulatory antibodies in the treatment of neoplastic disorders
08/08/2002	WO2002060484A1 Use of cd23 antagonists for the treatment of neoplastic disorders
08/08/2002	WO2002060483A2 Perylenequinones for use as photosensitizers and sonosensitizers
08/08/2002	WO2002060482A2 Perylenequinones for use with immunotherapy agents
08/08/2002	WO2002060468A2 Antiviral activities of primate theta defensins and mammalian cathelicidins
08/08/2002	WO2002060458A2 Compositions and method of tissue superoxygenation
08/08/2002	WO2002060452A2 Use of carbohydrates for eliminating intestinal infections in animals
08/08/2002	WO2002060450A1 Pyrimidine compounds and methods for making and using the same
08/08/2002	WO2002060447A1 Receptor selective cannabimimetic aminoalkylindoles
08/08/2002	WO2002060445A1 Kappa opioid receptor ligands
08/08/2002	WO2002060443A1 Thiazolidinediones
08/08/2002	WO2002060433A1 Watery solution of copper and zinc chelates for the treatment of animals
08/08/2002	WO2002060412A2 Stabilised polymeric aerosols for pulmonary gene delivery
08/08/2002	WO2002060379A2 Composition comprising extracts of flos lonicerae, fructus forsythiae and radix scutellariae, uses and preparation thereof
08/08/2002	WO2002060378A2 Substituted aryl compounds as cyclooxygenase-2 selective inhibitors, compositions and methods of use
08/08/2002	WO2002046208A3 Method of producing biospecific molecules by protein trans-splicing
08/08/2002	WO2002040516A3 Helicobacter cysteine rich protein a (hcpa) and uses thereof
08/08/2002	WO2002038541A9 Cyanopyrrolidine derivatives
08/08/2002	WO2002034716A3 Pyrrolidine modulators of ccr5 chemokine receptor activity
08/08/2002	WO2002032900A3 Aryl or heteroaryl fused imidazole compounds as anti-inflammatory and analgesic agents
08/08/2002	WO2002030455A3 Agents for the treatment of viral infections
08/08/2002	WO2002024650A3 Pyridinone and pyridinethione derivatives having hiv inhibiting properties
08/08/2002	WO2002024145A3 Antiviral substances from plant cuticular and epicuticular material
08/08/2002	WO2002022161A3 The diagnosis, prevention, and/or treatment of atherosclerosis and underlying and/or related diseases
08/08/2002	WO2002020762A3 Tnf receptor-like molecules and uses thereof
08/08/2002	WO2002015722A3 Treatment of helicobacter with isothiocyanates
08/08/2002	WO2002010140A3 Imidazolyl derivatives
08/08/2002	WO2002009690A3 Pharmaceutical composition comprising a photochemotherapeutic agent and a mucoadhesive agent
08/08/2002	WO2002007742A3 Bacteriophage having multiple host range
08/08/2002	WO2002007729A9 Non-sedating barbiturate compounds as neuroprotective agents
08/08/2002	WO2002006189A3 Aniline derivatives
08/08/2002	WO2002005801A3 Compositions containing diacyltartaric salts of (e)-metanicotine
08/08/2002	WO2002000885A3 Assembly of wild-type and chimeric influenza virus-like particles (vlps)
08/08/2002	WO2002000695A3 Peptides for the preparation of vaccines against bordetella pertussis and bordetella parapertussis
08/08/2002	WO2001098268A3 Piperidine amides as modulators of chemokine receptor activity
08/08/2002	WO2001096546A3 Protein phosphatases
08/08/2002	WO2001096379A3 Immunization of dairy cattle with chimeric gapc protein against streptococcus infection
08/08/2002	WO2001095934A3 The use of plant oil-bodies in vaccine delivery systems
08/08/2002	WO2001093840A3 Ligands of integrin receptors
08/08/2002	WO2001092547A3 Modified bovine adenovirus having altered tropism
08/08/2002	WO2001091786A3 Diagnosis and treatment of herpes infections
08/08/2002	WO2001091536A3 Genetic vaccine that mimics natural viral infection and induces long-lasting immunity to pathogens
08/08/2002	WO2001085664A3 Compounds and methods for regulating bacterial growth and pathogenesis
08/08/2002	WO2001081585A3 A thymus expressed human cytochrome p450 (p450tec)
08/08/2002	WO2001077134A3 Process for the preparation of 6-o-propargyl erythromycin derivatives
08/08/2002	WO2001070941A3 An infective endogenous retrovirus in association with demyelinating diseases e.g. multiple sclerosis
08/08/2002	WO2001068117A3 Immunostimulatory polynucleotide sequences for use in preventing and treating viral infections
08/08/2002	WO2001068116A3 Immunostimulatory polynucleotide sequences for use in preventing and treating respiratory viral infections
08/08/2002	WO2001068103A3 Treatment of herpes infection using immunomodulatory polynucleotide sequences
08/08/2002	WO2001068077A3 Immunostimulatory polynucleotide sequences for use in preventing and treating viral infections
08/08/2002	WO2001051641A9 Irak-4: compositions and methods of use
08/08/2002	WO2001051073A9 The parenteral use of bacterial phage associated lysing enzymes for the therapeutic treatment of bacterial infections
08/08/2002	WO2001036419A9 Use of 9-substituted hypoxanthine derivatives to stimulate regeneration of nervous tissue

1 ... 1275 1276 1277 1278 1279 1280 1281 1282 1283 1284 1285 1286 1287 1288 1289 1290 1291 1292 1293 1294 1295 ... 1798